1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Massachusetts >
  6. RestorGenex Acquires Paloma Pharmaceuticals

M&A Deal Summary

RestorGenex Acquires Paloma Pharmaceuticals

On April 1, 2014, RestorGenex acquired life science company Paloma Pharmaceuticals

Acquisition Highlights
  • This is RestorGenex’s 1st transaction in the Life Science sector.
  • This is RestorGenex’s 1st transaction in the United States.
  • This is RestorGenex’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2014-04-01
Target Paloma Pharmaceuticals
Sector Life Science
Buyer(s) RestorGenex
Deal Type Add-on Acquisition

Target

Paloma Pharmaceuticals

Jamaica Plain, Massachusetts, United States
Paloma Pharmaceuticals, Inc. has developed a non-steroidal, synthetic, small molecule drug library through computational design, synthetic and medicinal chemistry, resulting in a family of anti-tumor agents, "Palomids".

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

RestorGenex

Buffalo Grove, Illinois, United States
Category Company
Sector Life Science
Employees8
DESCRIPTION

RestorGenex Corp. is a biopharmaceutical company with an initial focus on dermatology, ocular diseases and women's health. RestorGenex is based in Buffalo Grove, Illinois.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2014 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal